The funded project is intended to design and acquire phosphorodiamidate morpholino oligos ("PMOs") FROM Gene Tools, Inc that are intended to cause exon skipping in human cells such that a truncated form of gamma sarcoglycan is produced.
|Effective start/end date
|10/1/14 → 9/30/15
- Kurt + Peter Foundation (Agmt 10/27/14)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.